Filter by: patients
What is Pimavanserin?

Pimavanserin is a drug in development for treatment of different types of psychoses, including schizophrenia.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 1 1 Efficacy_major

See 1 patient currently taking Pimavanserin

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
1
Mild
0
None
0

Commonly reported side effects, conditions, and hospitalizations associated with Pimavanserin

Dry mouth at night 1
Stomach pain 1
Back pain 1

Reported Dosages

  40 mg daily
  1 Number of Patients: 1  

Currently Taking Pimavanserin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Pimavanserin

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Pimavanserin

Very
0 0%
Somewhat
1 100%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

Cost of Pimavanserin

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on February 11, 2012.